Decreasing Knee Injury Risk Factors With Neuromuscular Training

NCT01433718 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-04-21

No results posted yet for this study

Summary

Anterior cruciate ligament (ACL) tears are disabling injuries that place a significant burden on the athlete. Roughly 80% of these injuries are linked to a noncontact mechanism, with more than 70% of them occurring while landing from a jump. Female athletes are at higher risk of sustaining a noncontact ACL injury due to the higher number of risk factors that they possess compared to their male counterparts. Due to this statistic, ACL prevention programs have been developed over the past 15 years in attempt to reduce this risk among the female athletic population. These programs have been shown to reduce the rate of noncontact ACL injuries in females by correcting the risk factors associated with them. However, it remains unclear as to whether these positive results are solely due to the program or a higher exercise workload in its participants. The purpose of this study is to evaluate the effectiveness that an ACL prevention program has on modifying at-risk landing mechanics (associated with noncontact ACL injury) compared to a resistance training program of equal workload.

Conditions

  • ACL
  • Anterior Cruciate Ligament Injury

Interventions

PROCEDURE

Neuromuscular and Resistance Training

1 hour/session, 3 sessions/week, 6 weeks

Sponsors & Collaborators

  • National Athletic Trainers' Association Research & Education Foundation (NATA Foundation)

    collaborator OTHER
  • Ohio University

    lead OTHER

Principal Investigators

  • Conrad M Gabler, B.S. · Graduate Athletic Training Student

  • Brian G Ragan, Ph.D. · Athletic Training Program Assistant Professor and Research Coordinator

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
20 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2012-02-29
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01433718 on ClinicalTrials.gov